Incidence, Treatment, and Survival of Synchronous Peritoneal Metastases in Pancreatic Cancer-Reference-Cited by-同舟云学术

Incidence, Treatment, and Survival of Synchronous Peritoneal Metastases in Pancreatic Cancer

Published:2021-07 Issue:6 Volume:50 Page:827-833
ISSN:1536-4828
Container-title:Pancreas
language:en
Short-container-title:Pancreas

Author:

Rijken Anouk,Bakkers Checca,van Erning Felice N.,van der Geest Lydia G.,de Vos-Geelen Judith,Besselink Marc G.,Lemmens Valery E.,de Hingh Ignace H.J.T.,

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Endocrinology,Hepatology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference24 articles.

1. Survival in patients with primary liver cancer, gallbladder and extrahepatic biliary tract cancer and pancreatic cancer in Europe 1999–2007: results of EUROCARE-5;Eur J Cancer,2015

2. Nationwide trends in incidence, treatment and survival of pancreatic ductal adenocarcinoma;Eur J Cancer,2020

3. Trends in treatment and survival of patients with nonresected, nonmetastatic pancreatic cancer: a population-based study;Cancer Med,2018

4. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer;N Engl J Med,2004

5. Treatment of pancreatic cancer-neoadjuvant treatment in borderline resectable/locally advanced pancreatic cancer;Transl Gastroenterol Hepatol,2019

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploiting a subtype-specific mitochondrial vulnerability for successful treatment of colorectal peritoneal metastases;Cell Reports Medicine;2024-05

2. Resectable Pancreatic Cancer With Peritoneal Metastases: Is Cytoreduction Combined With Hipec Effective and When?;2024-01-05

3. Primary resistance to immunotherapy in patients with a dMMR/MSI metastatic gastrointestinal cancer: who is at risk? An AGEO real-world study;British Journal of Cancer;2023-12-15

4. Prognosticators of survival in patients with metastatic pancreatic cancer and ascites;ESMO Open;2023-12

5. Establishment of Patient-Derived Organoids Using Ascitic or Pleural Fluid from Cancer Patients;Cancer Research and Treatment;2023-10-15